Doing business with the NIH

Nature Biotechnology

Volumn 24, Issue 1, 2006, Pages 17-20

  Ben Menachem, Gil ^b   Ferguson, Steven M ^b   Balakrishnan, Krishna ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; INVESTMENTS;

BIOTECH ENTREPRENEUR; NON-DILUTIVE FUNDING; US NATIONAL INSTITUTES OF HEALTH (NIH);

COMMERCE;

BORTEZOMIB; NICOTINE VACCINE; PALIFERMIN; PALIVIZUMAB; POLYSACCHARIDE VACCINE; STAPHVAX; UNCLASSIFIED DRUG; VACCINE;

BIOTECHNOLOGY; COMMERCIAL PHENOMENA; DRUG INDUSTRY; FUNDING; HEALTH CARE ORGANIZATION; HUMAN; PRIORITY JOURNAL; REVIEW; TECHNOLOGY; TRAINING; UNITED STATES;

BIOTECHNOLOGY; INDUSTRY; INTERINSTITUTIONAL RELATIONS; LICENSURE; NATIONAL INSTITUTES OF HEALTH (U.S.); UNITED STATES;

EID: 30544453559     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. http://ott.od.nih.gov/techdev.html
2. http://grants.nih.gov/grants/funding/sbir.htm
3. http://www.house.gov/science/hearings/ets05/june28/charter.pdf
4. http://grants.nih.gov/grants/funding/sbirsttr_tidbits_april2004.doc
5. http://grants.nih.gov/grants/funding/conferences.htm
6. http://grants.nih.gov/grants/funding/sbirsttr1/SBIR_STTR_ContactInfo.pdf
7. http://crisp.cit.nih.gov/
8. http://www.ott.nih.gov/pdfs/TTstats04.pdf
9. Ramakrishnan, V., Chen, J. & Balakrishnan, K. Effective Strategies for Marketing Biomedical Inventions: Lessons Learnt From NIH License Leads. J. Med. Mark. 5, 342-352 (2005).
10. http://www.ott.nih.gov/db/newtech.asp
11. http://www.ott.nih.gov/techabs.html
12. http://www.ott.nih.gov/join_ott.html
13. http://www.ott.nih.gov/resper_ott.html
14. http://ott.od.nih.gov/intern.html
15. http://www3.nci.nih.gov/bbig/
16. http://researchfestival.nih.gov/
17. http://ott.od.nih.gov/tdc.html